Cargando…
Branchpoints as potential targets of exon-skipping therapies for genetic disorders
Fukutin (FKTN) c.647+2084G>T creates a pseudo-exon with a premature stop codon, which causes Fukuyama congenital muscular dystrophy (FCMD). We aimed to ameliorate aberrant splicing of FKTN caused by this variant. We screened compounds focusing on splicing regulation using the c.647+2084G>T spl...
Autores principales: | Ohara, Hiroaki, Hosokawa, Motoyasu, Awaya, Tomonari, Hagiwara, Atsuko, Kurosawa, Ryo, Sako, Yukiya, Ogawa, Megumu, Ogasawara, Masashi, Noguchi, Satoru, Goto, Yuichi, Takahashi, Ryosuke, Nishino, Ichizo, Hagiwara, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403725/ https://www.ncbi.nlm.nih.gov/pubmed/37547287 http://dx.doi.org/10.1016/j.omtn.2023.07.011 |
Ejemplares similares
-
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
por: Sako, Yukiya, et al.
Publicado: (2017) -
Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy
por: Okubo, Mariko, et al.
Publicado: (2020) -
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
por: Hosokawa, Motoyasu, et al.
Publicado: (2023) -
Splicing Reporter Mice Revealed the Evolutionally Conserved Switching Mechanism of Tissue-Specific Alternative Exon Selection
por: Takeuchi, Akihide, et al.
Publicado: (2010) -
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
por: Nishida, Atsushi, et al.
Publicado: (2011)